All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl

Slides:

Advertisements

Similar presentations

Sinus Cancer (C30, C31): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Ad Hoc Sex Survival (%)

Advertisements

Ovarian Cancer (C56.9, C57.0-C57.4, C57.7):

Breast Cancer (C50): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Mesothelioma (C45): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Hypopharyngeal Cancer (C12, C13):

Eye Cancer (C69): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Uterine Cancer (C54-C55): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK Northern.

Colon Cancer (C18): Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries Data consists of both observed and predicted.

Hodgkin Lymphoma Subtypes:

Pancreatic Cancer (C25):

Salivary Gland Cancer (C07, C08):

Cancer of Unknown Primary (C77-C80): 2013

Head & Neck Cancer (C00-C14, C30-C32): 2014

Prostate Cancer (C61): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK Northern England.

Liver Cancer (C22): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Kidney Cancer (C64-C66, C68): Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries Data consists of both observed.

All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl

Thyroid Cancer (C73): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%) Survival.

Gallbladder Cancer (C23-C24):

Uterine Cancer (C54-C55): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Females, UK Northern.

In Situ Breast Carcinoma (D05): 2014

Anal Cancer (C21): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%) Survival.

Non-Melanoma Skin Cancer (C44): 2014

Hodgkin Lymphoma Subtypes:

Oral Cavity Cancer (C03, C04, C05, C06):

One-, Five- and Ten-Year Net Survival (%), Men, Aged 15-90, England

Lung Cancer (C33-C34): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Kidney Cancer (C64-C66,C68): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England.

Bone Sarcoma (C40-C41): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

per 100,000 Population, Females, UK

Malignant Melanoma (C43): 2014

Chronic Myeloid Leukaemia (C92.1): 2014

Oral Cancer (C00-C06,C09-C10,C12-C14): 2014

Hodgkin Lymphoma (C81): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Bowel Cancer (C18-C20): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Oesophageal Cancer (C15): 2014

Statistically Significant Cancers, Males, England,

Non-Hodgkin Lymphoma (C82-C86): 2014

Myeloma (C90): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Chronic Lymphocytic Leukaemia (C91.1): 2014

Soft Tissue Sarcoma: Relative Survival (%), Adults Aged , UK 1-Year

Tongue Cancer (C01, C02 excluding C02.4):

Acute Myeloid Leukaemia (C92. 0, C92. 4, C92. 5, C92. 6, C92. 8, C93

Stomach cancer Scotland, Patients diagnosed

Penile Cancer (C60): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Males, UK Northern England.

Bladder Cancer (C67): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Anal Cancer (C21): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Pancreatic Cancer (C25): 2014

per 100,000 Population, Females, UK

Eye Cancer (C69): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Leukaemia (C91-C95): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Acute Lymphoblastic Leukaemia (C91.0): 2014

Prostate Cancer (C61): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Males, UK Northern England.

Gallbladder Cancer (C23): 2014

Cancer of Unknown Primary (C77-C80): 2014

Oropharyngeal Cancer (C09, C10, C02.4):

Cancer Patient Experience Survey, by Sex, England Female Male Persons

Ovarian Cancer (C56-C57.4): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Females, UK Northern.

Vaginal or Vulval (C51-C52):

The Three Most Common Cancers: 2013

Breast Cancer (C50): 2014 Numbers of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Scotland.

Stomach Cancer (C16): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Thyroid Cancer (C73): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Laryngeal Cancer (C32): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

All Teenagers' and Young Adults' Cancers:

Penile Cancer (C60): One-, Five- and Ten-Year Net Survival (%), Men, Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%) Survival.

All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl

Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75

Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75

Bone Sarcoma (C40-C41): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%)

Presentation transcript:

All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl. C44): 2007-2011 European Age-Standardised (AS) Mortality Rates by Deprivation Quintile, England 1 - least 5 - most deprived 2 3 4 deprived Overall AS Rate 164.1 181.4 197.7 224.7 262.0 201.5 AS Rate - 95% LCL 162.8 180.1 196.2 223.1 260.1 200.8 Male AS Rate - 95% UCL 165.4 182.8 199.2 226.4 264.0 202.2 AS Rate Ratio 1.0 1.1 1.2 1.4 1.6 Yearly Excess Cases 1,262 2,245 3,497 4,696 11,700 AS Rate 123.7 134.3 143.7 159.3 182.7 146.4 AS Rate - 95% LCL 122.7 133.2 142.6 158.1 181.2 145.9 Female AS Rate - 95% UCL 124.8 135.3 144.8 160.5 184.1 147.0 AS Rate Ratio 1.0 1.1 1.2 1.3 1.5 Yearly Excess Cases 907 1,629 2,482 3,387 8,405 AS Rate 141.1 154.1 166.2 186.4 216.4 169.6 AS Rate - 95% LCL 140.2 153.3 165.3 185.4 215.2 169.2 Persons AS Rate - 95% UCL 141.9 155.0 167.1 187.4 217.6 170.0 AS Rate Ratio 1.0 1.1 1.2 1.3 1.5 Yearly Excess Cases 2,038 3,636 5,675 7,848 19,196 95% LCL and 95% UCL are the 95% lower and upper confidence limits around the AS Rate Source: cruk.org/cancerstats You are welcome to reuse this Cancer Research UK statistics content for your own work. Credit us as authors by referencing Cancer Research UK as the primary source. Suggested style: Cancer Research UK, full URL of the page, Accessed [month] [year].